STEVENSON, Md.--(BUSINESS WIRE)--The law firm of Brower Piven, A Professional Corporation, is investigating potential securities fraud claims against Celsion Corporation (“Celsion”) (NASDAQ: CLSN) regarding whether Celsion may have issued materially false or misleading information to investors before announcing on January 31, 2013 that its ThermoDox liver cancer treatment failed in a study and did not meet its primary endpoint.
If you purchased or acquired Celsion securities between January 1, 2012 and January 30, 2013 and have suffered a loss on your investment, or if you believe you have information relating to the subject matter of our investigation, you may email or call Brower Piven, who will, without obligation or cost to you, communicate with you regarding the matter and attempt to answer your questions. You may contact Brower Piven by email at hoffman@browerpiven.com, by calling 410/415-6616, or by writing to Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.